Diverging Paths: Major Investors Split on IonQ’s Quantum Future

IonQ US46222L1089

As U.S. markets resume trading following the Presidents' Day holiday, attention turns to quantum computing specialist IonQ. The company finds itself at a crossroads, caught between conflicting moves by its largest shareholders and the lingering impact of a sharply critical short-seller report.

All eyes are on February 25, 2026. After the market closes that day, IonQ is scheduled to release its financial results for the fourth quarter and the full year 2025. Investors are anticipating clear commentary from management addressing recent allegations, with a particular focus on the company's order pipeline and its relationship with the Department of Defense. This earnings release is widely seen as a pivotal moment that could validate either the concerns raised by short-sellers or the long-term confidence shown by certain institutional backers.

A Tale of Two Institutions

Recent regulatory filings with the SEC reveal a striking divergence in strategy among major stakeholders, based on positions held as of the December 31, 2025 reporting date.

On one side, asset management giant BlackRock has significantly increased its stake. According to a filing submitted in late January, the firm now holds 27.8 million shares, representing a 7.8% ownership interest in IonQ. This marks an increase of approximately 12.6 million shares compared to its previously disclosed position of about 15.1 million.

Taking the opposite approach, Morgan Stanley has substantially reduced its exposure. A February 12 disclosure shows the investment bank lowered its holding to 17.1 million shares, or 4.8% of the company. This reduction of roughly 3.2 million shares from a previously reported 20.3 million brings Morgan Stanley's ownership below the 5% threshold that triggers mandatory reporting requirements.

Short-Seller Allegations Weigh on Sentiment

This institutional split unfolds against a backdrop of heightened uncertainty for IonQ. Earlier in February, Wolfpack Research published a report alleging the company lost key Pentagon contracts and questioning the transparency of its revenue recognition practices.

The allegations triggered significant volatility in the stock. IonQ's share price closed at $34.11 on the last trading day before the holiday. Skepticism regarding future contract awards, as voiced by the short-selling firm, continues to overhang the equity.

The upcoming financial report will likely determine whether Wolfpack Research's concerns have merit or if BlackRock's substantial vote of confidence in IonQ's technological trajectory is well-founded.